Approved TherapeuticAugust 5, 2026
Semaglutide
Ozempic
Type 2 diabetes · Chronic weight management
Tier 1Approved
Loading Daily Peptide Guide…
Search peptides, conditions, blends and clinical research with transparent evidence and safety ratings.
A fast read on evidence, status and safety—each kept independent.
Ozempic
Type 2 diabetes · Chronic weight management
Mounjaro
Type 2 diabetes · Chronic weight management
LY3437943
Obesity · Type 2 diabetes
SS-31
Barth syndrome · Mitochondrial disease research
Popularity is not evidence of effectiveness or safety.
Retatrutide is a clinical-stage asset. Trial status and sponsor-reported findings remain time-sensitive and indication-specific.
Read the dossierOne score never stands in for another.
Editorial reviews of hype, failed programs, regulatory actions and product-quality risk.
A claim-by-claim look at why animal findings and anecdotes do not establish human recovery efficacy.
Read analysis →Why a recognizable peptide name does not prove identity, potency, sterility or equivalence.
Read analysis →How endpoints, tolerability and trial design change the meaning of a headline result.
Read analysis →Get the field guide plus a concise monthly briefing on evidence shifts, clinical catalysts and regulatory context.